Extracellular vesicle world
Extracellular vesicles (EVs) with their diameter ranging from a few nm to 1 µm, play a crucial role as carriers in facilitating intercellular communication. At Jotbody, we are dedicated to offering high-quality and consistent one-stop research solutions for EVs, catering to the diverse needs of our customers.
To support your scientific advancements, we offer a diverse range of cutting-edge services tailored specifically for EV research:
From our publications:
- Red blood cell-derived extracellular vesicles display endogenous antiviral effects and enhance the efficacy of antiviral oligonucleotide therapy. ACS Nano 2023 17 (21), 21639-21661
- Red blood cell extracellular vesicles deliver therapeutic siRNAs to skeletal muscles for treatment of cancer cachexia. Mol Ther. 2023 May 3;31(5):1418-1436
- CD33-targeting extracellular vesicles deliver antisense oligonucleotides against FLT3-ITD and miR-125b for specific treatment of acute myeloid leukaemia. Cell Prolif. 2022 Sep;55(9):e13255
- Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy. Theranostics. 2022 Apr 11;12(7):3288-3315
- Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery. J ExtracellVesicles. 2021;10:e12057
- Efficient RNA drug delivery using red blood cell extracellular vesicles. Nat Commun 9, 2359 (2018)